HIV-related tuberculosis in sub-Saharan Africa: More drugs or more of the same?

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 7, 2003, Pages 609-610

  Helbling, Peter ^a  

^a FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

AFRICA SOUTH OF THE SAHARA; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SHORT COURSE THERAPY;

AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; RECURRENCE; TUBERCULOSIS;

EID: 0038451510     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Raviglione M C, Harries A D, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa. AIDS 1997; 11 (suppl B): S115-S123.
2. Kapp C. Global fund faces uncertain future as cash runs low. Lancet 2002; 360: 1225.
3. Harries A D, Chimzizi R B, Nyirenda T E, van Gorkom J, Salaniponi F M. Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for TB control programmes? Int J Tuberc Lung Dis 2003; 7: 616-622.
4. Creese A, Floyd K, Alban A, Guiness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002; 359: 1635-1642.
5. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064.
6. Harries A D, Nyangulu D S, Hargreaves N J, Kaluwa O, Salaniponi F M. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001; 358: 410-414.
7. Perriens J H, St Louis M E, Mukadi Y B, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995; 332: 779-784.
8. Fitzgerald D, Desvarieux M, Severe P, Joseph P, Johnson W D Jr, Pape J W. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 2000; 356: 1470-1474.
9. Fidler D P. Emerging trends in international law concerning global infectious disease control. Emerg Infect Dis 2003; 9: 285-290.
10. Jonsen A. Bentham in a box: technology assessment and health care allocation. Law Med Health Care 1986; 14: 172-174.
11. Hadorn D C. Setting health care priorities in Oregon: Cost-effectiveness meets the rule of rescue. JAMA 1991; 265: 2218-2225.